Therapy Areas: Vaccines
Latigo Biotherapeutics names new chief executive officer
23 July 2024 - Latigo Biotherapeutics Inc., a California-based clinical-stage biotechnology company, announced on Monday that it has named Nima Farzan, MBA as its new chief executive officer (CEO).Far...
Valneva receives CEPI funding to boost access to world's first chikungunya vaccine
22 July 2024 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) and and the Coalition for Epidemic Preparedness Innovations (CEPI) announced on Monday that CEPI has awarded Valneva an add...
Bavarian Nordic's chikungunya vaccine receives validation from EMA for accelerated review
18 July 2024 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Thursday that the European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) ...
GSK secures global rights to CureVac's mRNA vaccines in new licensing deal
3 July 2024 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) and biotech firm CureVac N.V. (Nasdaq: CVAC) announced on Wednesday that they have restructured their collaboration into a new licensing...
P95 BV acquires 4Clinics
3 July 2024 - P95 BV ('P95'), a Belgium-based global company involved in clinical and epidemiology research solutions, with a focus on vaccines and infectious diseases, announced on Tuesday ...
INOVIO names new chief commercial officer
3 July 2024 - INOVIO (NASDAQ:INO), an American biotechnology company, announced on Tuesday that it has named Steven Egge as its new chief commercial officer.In the new role, Egge will head the firm�...